Editor’s Note: Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer

Editor’s Note: Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-01-01
Series:	Integrative Cancer Therapies
Online Access:	https://doi.org/10.1177/15347354241312737
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glutamine deprivation confers immunotherapy resistance by inhibiting IFN-γ signaling in cancer cells
by: Zhiwei Yuan, et al.
Published: (2025-03-01)

Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer
by: Jingyang Li, et al.
Published: (2025-02-01)

Glutamine missense suppressor transfer RNAs inhibit polyglutamine aggregation
by: Rasangi Tennakoon, et al.
Published: (2025-03-01)

Editor's note
by: Marie-Louise Karttunen
Published: (2011-01-01)

Editors’ Note
by: Alberto Raposo, et al.
Published: (2019-12-01)

Editor’s Note
Published: (1996-01-01)

Editor’s Note
Published: (1996-01-01)

Editor's Note
by: Robyn Williams, et al.
Published: (2022-02-01)

Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
by: Maria Ignez Freitas Melro Braghiroli, et al.
Published: (2024-01-01)

New Editor's Note
by: Alberto Raposo
Published: (2013-08-01)

Guest Editors’ Note
by: Malte Rehbein, et al.
Published: (2011-06-01)

Oral Glutamine Supplement Inhibits Ascites Formation in Peritoneal Carcinomatosis Mouse Model
by: Ming-Jen Chen, et al.
Published: (2013-01-01)

Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
by: Ding Nan, et al.
Published: (2025-01-01)

Editor’s Note: Volume 13
by: Eric Murphy Selinger
Published: (2025-01-01)

Association between folate and glutamine metabolism and prognosis of kidney cancer
by: Jiaxuan Qin, et al.
Published: (2025-01-01)

Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer
by: Shiyun Chen, et al.
Published: (2025-01-01)

Glutamine and Its Effects on the Intestine
by: Paul E Hardy, et al.
Published: (1991-01-01)

Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival
by: Bárbara Mora-Lagos, et al.
Published: (2025-01-01)

RUNX2 enhances bladder cancer progression by promoting glutamine metabolism
by: Zhigang Huang, et al.
Published: (2025-02-01)

HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway
by: Yunan Liang, et al.
Published: (2024-10-01)

Glutamine Supplementation in Sick Children: Is It Beneficial?
by: Elise Mok, et al.
Published: (2011-01-01)

Correction: HOXB8 mediates resistance to cetuximab in colorectal cancer cells through activation of the STAT3 pathway
by: Yunan Liang, et al.
Published: (2025-01-01)

Cost–effectiveness of cetuximab combined with radiotherapy versus radiotherapy alone in locally advanced head and neck cancer in Spain
by: Ruth Alvarez Cabellos, et al.
Published: (2025-01-01)

Oxaliplatin-Loaded Chitosan Nanoparticles Decorated with Cetuximab Single-Chain Variable Fragment for Human Colorectal Cancer Treatment
by: Khadijeh Falahzadeh, et al.
Published: (2024-09-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

Oral Glutamine Supplementation Benefits Jejunum but Not Ileum
by: Paul E Hardy, et al.
Published: (1994-01-01)

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
by: Shuai Zhao, et al.
Published: (2025-02-01)

Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy
by: Robert M. Samstein, et al.
Published: (2014-01-01)

The role of glutamine in supporting gut health and neuropsychiatric factors
by: Brett J. Deters, et al.
Published: (2021-03-01)

Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
by: Hui Wang, et al.
Published: (2025-01-01)

Levistolide A and periplogenin inhibit the growth of gastric cancer cells in vitro and in vivo
by: Jia Li Guo, et al.
Published: (2023-03-01)

Comparative efficacy of programmed death ligand 1 inhibition and chemotherapy in advanced gastric or gastroesophageal junction cancer with combined positive score – a meta-analysis
by: Zakari Shaibu, et al.
Published: (2024-10-01)

Parchment Glutamine Index (PQI): A novel method to estimate glutamine deamidation levels in parchment collagen obtained from low-quality MALDI-TOF data
by: Nair, Bharath, et al.
Published: (2023-01-01)

Identification of glutamine as a potential therapeutic target in dry eye disease
by: Xiaoniao Chen, et al.
Published: (2025-01-01)

Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
by: M. S. El-Shimi, et al.
Published: (2015-01-01)

Improving vaccination uptake in pediatric Cochlear implant recipients
by: Lisa Jin, et al.
Published: (2018-09-01)

The Efficacy of Ramucirumab in the Treatment of Gastric or Gastroesophageal Junction Cancer: A Meta-Analysis of RCTs
by: Hongqiong Yang, et al.
Published: (2021-01-01)

Pengaruh Pemberian Glutamin pada Kemampuan Fagositosis Makrofag terhadap Pseudomonas Aeruginosa
by: Daslina ,, et al.
Published: (2015-09-01)

AMPK Activation in TET2 Downregulated Leukemia Cells Upon Glutamine Limitation
by: Ahsen Merve BAYRAK, et al.
Published: (2024-09-01)

SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2025-01-01)